KAITLYN HORNER: Open Payments
NPI 1477018083 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,373 in 156 payments from 17 companies in 2025. Trend: 2023 $2,465 · 2024 $2,319 · 2025 $3,373
Food & beverage: $3,274Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 35 | $669 |
| ABBVIE INC. | 21 | $607 |
| Janssen Biotech, Inc. | 20 | $465 |
| UCB, Inc. | 23 | $421 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| Novartis Pharmaceuticals Corporation | 12 | $216 |
| Lilly USA, LLC | 6 | $176 |
| SOBI, INC | 5 | $136 |
| E.R. Squibb & Sons, L.L.C. | 7 | $133 |
| Fresenius Kabi USA, LLC | 3 | $79 |
Products named: TREMFYA, RINVOQ, Bimzelx, KRYSTEXXA, SAPHNELO, COSENTYX, TALTZ, OTEZLA.
Industry payments across SC — which companies pay providers there.
